Litcius/Paper detail

Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial

Nils Venhoff, Wolfgang Schmidt, Raoul Bergner, Jürgen Rech, L. Unger, Hans‐Peter Tony, Stephanie Finzel, Ioana Andreica, David M. Kofler, Stefan M. Weiner, Peter Lamprecht, Hendrik Schulze‐Koops, Christine App, Effie Pournara, Meryl H. Mendelson, Christian Sieder, M. Maricos, Jens Thiel

2023The Lancet Rheumatology89 citationsDOI

Topics & Concepts

MedicineSecukinumabGiant cell arteritisPlaceboClinical endpointPrednisoloneInternal medicineTocilizumabClinical trialSurgeryVasculitisArthritisRheumatoid arthritisPathologyAlternative medicinePsoriatic arthritisDiseaseVasculitis and related conditionsOtitis Media and Relapsing PolychondritisRenal Diseases and Glomerulopathies